We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Investigator Admits Ignoring Trials, Receives FDA Warning Letter
Investigator Admits Ignoring Trials, Receives FDA Warning Letter
December 7, 2011
A principal investigator who confessed to disregarding her trial responsibilities received an FDA warning for “systemic failures” in trial conduct that include failing to personally execute or adequately oversee two trials, as well as protocol deviations.